JP2009102649A5 - - Google Patents

Download PDF

Info

Publication number
JP2009102649A5
JP2009102649A5 JP2009003472A JP2009003472A JP2009102649A5 JP 2009102649 A5 JP2009102649 A5 JP 2009102649A5 JP 2009003472 A JP2009003472 A JP 2009003472A JP 2009003472 A JP2009003472 A JP 2009003472A JP 2009102649 A5 JP2009102649 A5 JP 2009102649A5
Authority
JP
Japan
Prior art keywords
group
formula
carbon atoms
molecule
oxyalkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009003472A
Other languages
English (en)
Japanese (ja)
Other versions
JP5273589B2 (ja
JP2009102649A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009003472A priority Critical patent/JP5273589B2/ja
Priority claimed from JP2009003472A external-priority patent/JP5273589B2/ja
Publication of JP2009102649A publication Critical patent/JP2009102649A/ja
Publication of JP2009102649A5 publication Critical patent/JP2009102649A5/ja
Application granted granted Critical
Publication of JP5273589B2 publication Critical patent/JP5273589B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009003472A 2002-11-20 2009-01-09 生体関連物質、その製造方法およびその中間体 Expired - Lifetime JP5273589B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009003472A JP5273589B2 (ja) 2002-11-20 2009-01-09 生体関連物質、その製造方法およびその中間体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002337113 2002-11-20
JP2002337113 2002-11-20
JP2009003472A JP5273589B2 (ja) 2002-11-20 2009-01-09 生体関連物質、その製造方法およびその中間体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003388886A Division JP4412461B2 (ja) 2002-11-20 2003-11-19 修飾された生体関連物質、その製造方法および中間体

Publications (3)

Publication Number Publication Date
JP2009102649A JP2009102649A (ja) 2009-05-14
JP2009102649A5 true JP2009102649A5 (2) 2010-09-16
JP5273589B2 JP5273589B2 (ja) 2013-08-28

Family

ID=32321831

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003388886A Expired - Lifetime JP4412461B2 (ja) 2002-11-20 2003-11-19 修飾された生体関連物質、その製造方法および中間体
JP2009003472A Expired - Lifetime JP5273589B2 (ja) 2002-11-20 2009-01-09 生体関連物質、その製造方法およびその中間体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003388886A Expired - Lifetime JP4412461B2 (ja) 2002-11-20 2003-11-19 修飾された生体関連物質、その製造方法および中間体

Country Status (11)

Country Link
US (4) US20050058620A1 (2)
EP (3) EP1911789B1 (2)
JP (2) JP4412461B2 (2)
KR (1) KR100988733B1 (2)
CN (1) CN100402580C (2)
AT (1) ATE388186T1 (2)
AU (1) AU2003302031A1 (2)
CA (1) CA2502948C (2)
DE (1) DE60319568T2 (2)
IL (2) IL168238A (2)
WO (1) WO2004046222A1 (2)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7179617B2 (en) * 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
DE60336555D1 (de) 2002-06-21 2011-05-12 Novo Nordisk Healthcare Ag Pegylierte glykoformen von faktor vii
US8828373B2 (en) * 2002-11-20 2014-09-09 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance
US8003117B2 (en) * 2002-11-20 2011-08-23 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance
JP4412461B2 (ja) * 2002-11-20 2010-02-10 日油株式会社 修飾された生体関連物質、その製造方法および中間体
GEP20084487B (en) * 2002-12-26 2008-09-25 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
JP5207590B2 (ja) 2002-12-26 2013-06-12 マウンテン ビュー ファーマシューティカルズ,インコーポレイテッド 増強された生物学的能力を有するインターフェロン−βのポリマー結合体
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
NZ542094A (en) 2003-03-14 2008-12-24 Neose Technologies Inc Branched polymer conjugates comprising a peptide and water-soluble polymer chains
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
JP2007523630A (ja) 2003-05-09 2007-08-23 ネオス テクノロジーズ インコーポレイテッド ヒト成長ホルモングリコシル化突然変異体の組成と調合法
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
NZ592039A (en) * 2003-08-27 2013-03-28 Ophthotech Corp Combination therapy for the treatment of ocular neovascular disorders
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
NZ548123A (en) 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
KR20070042567A (ko) * 2004-08-31 2007-04-23 파마시아 앤드 업존 캄파니 엘엘씨 글리세롤 분지쇄 폴리에틸렌 글리콜 인간 성장 호르몬공액체, 이의 제조 방법 및 이의 사용 방법
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
PT2363414T (pt) * 2004-11-12 2022-08-04 Bayer Healthcare Llc Modificação de fviii direcionada a sítio
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US8012488B2 (en) 2005-02-18 2011-09-06 Nof Corporation Polyoxyalkylene derivative
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2975135A1 (en) * 2005-05-25 2016-01-20 Novo Nordisk A/S Glycopegylated factor IX
KR100735784B1 (ko) * 2005-07-20 2007-07-06 재단법인 목암생명공학연구소 인간 과립구콜로니자극인자 변이체 및 이의 화학적 접합물
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP1787660A1 (en) * 2005-11-22 2007-05-23 GBF Gesellschaft für Biotechnologische Forschung mbH New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
WO2007132956A1 (en) * 2006-05-12 2007-11-22 Dong-A Pharm.Co., Ltd. Polyethylene glycol-interferon alpha conjugate
EP2049144B8 (en) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylation of peptides via o-linked glycosylation sequences
JP5277599B2 (ja) * 2006-09-29 2013-08-28 日油株式会社 生分解性ポリオキシアルキレン誘導体の製造方法
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
ES2655734T3 (es) * 2006-10-04 2018-02-21 Novo Nordisk A/S Glicopéptidos y azúcares pegilados unidos a glicerol
KR101079993B1 (ko) * 2006-11-17 2011-11-04 동아제약주식회사 폴리에틸렌글리콜 과립구 콜로니 자극인자 접합체
JP5515224B2 (ja) 2007-02-28 2014-06-11 日油株式会社 多分岐鎖ポリオキシアルキレン誘導体
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
US20090246430A1 (en) 2008-03-28 2009-10-01 The Coca-Cola Company Bio-based polyethylene terephthalate polymer and method of making same
EP2403894B1 (en) 2009-03-03 2016-06-01 The Coca-Cola Company Bio-based polyethylene terephthalate packaging and method of making thereof
US8067526B2 (en) * 2009-03-27 2011-11-29 Nof Corporation Method for producing polyoxalkylene derivative
US8716435B2 (en) 2009-03-31 2014-05-06 Nof Corporation Multibranched polyoxyalkylene compound and producing method thereof
JP5569787B2 (ja) * 2009-03-31 2014-08-13 日油株式会社 高分子量ポリエチレングリコール化合物の精製方法
US8816099B2 (en) * 2010-03-31 2014-08-26 Nof Corporation Polyfunctional polyoxyalkylene compound, and producing method and intermediate thereof
WO2011143274A1 (en) 2010-05-10 2011-11-17 Perseid Therapeutics Polypeptide inhibitors of vla4
KR20130115086A (ko) 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
US10040761B2 (en) * 2010-06-25 2018-08-07 Nof Corporation Branched hetero polyethylene glycol and intermediate
ES2706066T3 (es) 2010-07-02 2019-03-27 Univ Health Network Procedimiento dirigido a enfermedades mutantes con PTEN y composiciones para las mismas
JP5949037B2 (ja) 2011-03-30 2016-07-06 日油株式会社 末端に複数の水酸基を有するポリオキシエチレン誘導体
JP6508506B2 (ja) 2013-03-25 2019-05-08 日油株式会社 ベンジリデンアセタールリンカーを有する親水性ポリマー誘導体
EP2980115B1 (en) 2013-03-27 2019-03-06 NOF Corporation Purification method for polyethylene glycol having a single amino group
DK4374873T3 (da) 2013-07-12 2025-11-03 Astellas Us Llc Middel til brug ved behandling eller forebyggelse af oftalmologiske tilstande
CN103881084B (zh) * 2014-03-14 2016-09-28 厦门赛诺邦格生物科技股份有限公司 一种支化聚乙二醇的磷脂类衍生物及其组成的脂质膜结构体
JPWO2017043653A1 (ja) * 2015-09-11 2018-06-28 国立大学法人 東京大学 タンパク質を安定化するための化合物
US10745518B2 (en) * 2016-04-28 2020-08-18 Nof Corporation Branching-type polyoxyethylene compound and contact lens
WO2018066692A1 (ja) 2016-10-07 2018-04-12 国立大学法人東京工業大学 分岐型ヘテロ単分散ポリエチレングリコール、その製造方法、及びその結合体
JP6935059B2 (ja) 2017-03-30 2021-09-15 日油株式会社 カルボキシル基を一つ有するポリエチレングリコールの精製方法
JP7216332B2 (ja) * 2018-03-20 2023-02-01 日油株式会社 分岐型単分散ポリエチレングリコール、中間体およびその製造方法
US12441776B2 (en) 2018-11-30 2025-10-14 Eirgen Pharma Ltd. Oxyntomodulin peptide analog formulations
WO2021132123A1 (ja) 2019-12-27 2021-07-01 日油株式会社 分岐型ポリエチレングリコールの精製方法
US12304999B2 (en) 2019-12-27 2025-05-20 Nof Corporation Method for purifying polyethylene glycol compound
US20250197564A1 (en) 2022-03-09 2025-06-19 Nof Corporation Method for producing polyoxyethylene derivative, method for quantitating polyoxyethylene compound, and labeling reagent for analysis use
CA3250008A1 (en) 2022-03-17 2025-03-04 Nof Corporation PROCESS FOR PRODUCING A POLYETHYLENE GLYCOL DERIVATIVE
WO2025070508A1 (ja) 2023-09-27 2025-04-03 日油株式会社 末端にカルボキシル基を有するポリエチレングリコール誘導体の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025807A1 (de) * 1980-07-08 1982-02-04 Th. Goldschmidt Ag, 4300 Essen Verfahren zur herstellung von polyaethern unter erhalt von mindestens zwei freien hydroxylgruppen am startalkohol
JPH02242823A (ja) * 1989-03-02 1990-09-27 Kiyouseki Seihin Gijutsu Kenkyusho:Kk シアノエチル化ポリエーテルポリオール及び該化合物を有効成分として含有する冷凍機油
US5118448A (en) * 1990-10-19 1992-06-02 Arco Chemical Technology, L.P. Process for producing esterified alkoxylated polyols
JP3218755B2 (ja) * 1992-11-12 2001-10-15 日本油脂株式会社 グリセリンエーテルエステル
JP3067541B2 (ja) 1994-08-23 2000-07-17 日本油脂株式会社 グリセリンポリアルキレングリコールエーテル誘導体及びその製造方法
JP3921781B2 (ja) * 1998-02-12 2007-05-30 日本油脂株式会社 カルボキシル基含有ポリオキシアルキレン化合物
JP4055250B2 (ja) * 1998-06-15 2008-03-05 日油株式会社 アミノ基含有ポリオキシアルキレン化合物
JP2000230000A (ja) * 1999-02-08 2000-08-22 Hokkaido Univ 一酸化窒素代謝物−ポリオキシアルキレン−ヘモグロビン結合体
JP4123856B2 (ja) * 2001-07-31 2008-07-23 日油株式会社 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法
JP4412461B2 (ja) 2002-11-20 2010-02-10 日油株式会社 修飾された生体関連物質、その製造方法および中間体
US8003117B2 (en) 2002-11-20 2011-08-23 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance

Similar Documents

Publication Publication Date Title
JP2009102649A5 (2)
JP2006505634A5 (2)
JP2009521545A5 (2)
JP2008514418A5 (2)
JP2010530014A5 (2)
Krishna et al. Synthesis of poly (propyl ether imine) dendrimers and evaluation of their cytotoxic properties
CN103642050B (zh) 具有poss基的树枝状聚合物及其制备方法
JP2009522404A5 (2)
JP2012109092A5 (2)
JP2012109091A5 (2)
JP2012526548A5 (2)
JP2008510038A5 (2)
JP2013057058A5 (ja) ブロック共重合体の塗膜
JP2006509110A5 (ja) フルオロケミカル処理組成物及び汚染除去特性を繊維基材に与える方法
JP2008525619A5 (2)
EP2177556A3 (en) Silicone for preparing ophthalmic devices
JP2003201267A5 (2)
JP2012512286A5 (2)
JP2013514094A5 (2)
JP2013505327A5 (2)
JP2010511036A5 (2)
JP2013505333A5 (2)
JP2009536246A5 (2)
WO2016159071A1 (ja) 環状ベンジリデンアセタールリンカーを有する生分解性ポリエチレングリコール誘導体
JP2008266635A5 (ja) 活性エネルギー線硬化型液体組成物、水性インク及び液体カートリッジ